samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > oral liquid dispensation:
technology evolution
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Oral Liquid Dispensation:
Technology Evolution

One of the most common ways of dispensing a liquid medicine has been the spoon throughout history; this will inevitably continue for some time. Spoons in Europe commonly come in three sizes: coffee size (5ml), dessert size (10ml) and soup size (15ml). Spoons were introduced to French tables during the fourteenth century but without any standard volume; the different recognised sizes were defined later.

The origin of using spoons for medicine dispensation seems to be the desire to achieve consistent volume with an everyday utensil. The purpose of this article is not to give a detailed history of spoons, but simply to note that even now we are still using a very old method for medicine dispensation.

FROM THE SPOON TO THE SYRINGE

The main benefit of the spoon for the pharmaceutical industry is the simplicity of the device, adding no additional cost for product development, device manufacturing or specific packaging. Furthermore, the advantage for patients is...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Cedric Marmonier is the associated Managing Director of Rovipharm SAS. After working as Technical Manager in weaving machine manufacturing, and as a Business Manager with various plastic injection companies, Cedric first worked with plastic injection in 2002, and founded Rovipharm SAS in January 2006 in association with Mrs Emanuelle Boizet. His department is dedicated to the clean room production of pharmaceutical plastic product injection. As Business and Marketing Manager, Cedric brings his strong experience in plastic injection and business management.
spacer
Cedric Marmonier
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Restructure Announcement at Illingworth

As a rapidly growing company, Illingworth Research Group (Illingworth) has reflected on its goals, accomplishments and ambitious future growth plans. This has allowed us to consider opportunities for staff to explore their own growth and development possibilities within a rapidly changing landscape. With that in mind, Illingworth are announcing some significant and exciting changes to our organization. Illingworth remain committed to making patient involvement in clinical trials as stress free as possible and our strengthened management team and launch of our patient concierge service, PatientGO, in combination with global, mobile research nursing will ensure as many patients as possible have the chance to participate in the development of critical drugs, regardless of their geography or socioeconomic class.
More info >>

White Papers

galenIQ - The smart excipient

BENEO GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement